Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson’s disease: the LEAP-study

Table 2 Clinical rating scales

Clinical rating scale	Domain	Best score	Worst score
UPDRS	Parkinsonism	0	199
MMSE	Cognition	30	0
BDI-II	Depression	0	63
ALDS	Disability	100	0
EQ-5D	Quality of life	-	-
PDQ-39	Quality of life	0	100

UPDRS Unified Parkinson’s Disease Rating Scale, MMSE Mini Mental State Examination, BDI-II Beck Depression Inventory II, ALDS AMC Linear Disability Scale, EQ-5D European Quality of Life-5 Dimensions, PDQ-39 Parkinson’s Disease Questionnaire-39

ISSN: 1471-2377